Sign inJoin waitlistJoin the waitlist

HR

Harsha Ranganath

Physician · Franciscan Health Indianapolis

Credentials: · · · · · ·

History

Franciscan Health Indianapolis
2019–Present

Hematology and Medical Oncology
University of Tennessee College of Medicine
2015–2018
Internal Medicine
University of Tennessee Internal Medicine
2012–2015
Indiana University School of Medicine
2008–2012

Research

Nanoscale organization of hedgehog is essential for long-range signaling
Cell · 2008 · 123 citations
Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma
Case report · Journal of Immunotherapy · 2015 · First of 2 authors · 82 citations
Molecular phylogeny of the nasuta subgroup of Drosophila based on 12S rRNA, 16S rRNA and CoI mitochondrial genes, RAPD and ISSR polymorphisms
Genes & Genetic Systems · 2004 · Last of 3 authors · 12 citations

AJ
Amit Jain
3 papers · 3 as a fellow
FH
Felicia Hare
3 papers · 2 as a fellow
Gregory Vidal
3 papers
JM
Janice Mullins
3 papers
PV
Poojitha Valasareddy
3 papers · 2 as a fellow
Amina Chaudhry
2 papers · 2 as a fellow
LS
Lee Schwartzberg
2 papers
David Gandara
1 paper
DR
David Robins
1 paper
Michael Berry
1 paper
OJ
Omer Jamy
1 paper · 1 as a fellow
Rana Usman
1 paper · 1 as a resident

Clinical trials

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2023–2031
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2022–2027